2013
DOI: 10.1053/j.gastro.2013.07.041
|View full text |Cite
|
Sign up to set email alerts
|

Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

30
478
6
10

Year Published

2015
2015
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 755 publications
(524 citation statements)
references
References 71 publications
30
478
6
10
Order By: Relevance
“…Bernell et al [5] reported that the cumulative rate of intestinal resection in 1936 patients was 44%, 61%, and 71% at 1, 5, and 10 years after diagnosis, respectively, whereas the overall rate of surgery was 73.6%; in another systematic review, the rate of intestinal resection was 16.3%, 33.3%, and 46.6% at 1, 5, and 10 years after diagnosis, respectively [6] . In South China, the intestinal resection rate was reported to be 16.6%, 35.4%, 53%, and 94.5% at 1, 5, 10, and 30 years, respectively, after the onset of the disease [7] .…”
Section: Discussionmentioning
confidence: 99%
“…Bernell et al [5] reported that the cumulative rate of intestinal resection in 1936 patients was 44%, 61%, and 71% at 1, 5, and 10 years after diagnosis, respectively, whereas the overall rate of surgery was 73.6%; in another systematic review, the rate of intestinal resection was 16.3%, 33.3%, and 46.6% at 1, 5, and 10 years after diagnosis, respectively [6] . In South China, the intestinal resection rate was reported to be 16.6%, 35.4%, 53%, and 94.5% at 1, 5, 10, and 30 years, respectively, after the onset of the disease [7] .…”
Section: Discussionmentioning
confidence: 99%
“…This is a particularly difficult question to answer because the efficacy of drugs has such high variability and may change in an individual over time. Although surgery rates have decreased (17)(18)(19) and the need for surgery can be delayed in individuals by improved therapy with biologicals (20), the course of the disease over the years remains highly unpredictable. The evolving concept of tailored, 'personalized' management of IBD and treating the disease to an objective target are high in the priority of information needs of patients, and clinicians are beginning to realize that the personalized treatment approach can lead to higher remission rates and shorter initial disease duration (21).…”
Section: Data Presented As N (%)mentioning
confidence: 99%
“…Medical therapy advanced with the use of immunomodulators and the introduction of biologics. Changes in medical therapy and surgical practice over time might have influenced the natural history of the disease and possibly reduced surgery rates (1)(2)(3)(4)(5)(6)(7). However, epidemiological studies that have evaluated the effect of immunomodulators on surgery rates have yielded conflicting results (7)(8)(9).…”
Section: Introduction and Aimsmentioning
confidence: 99%